Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Accenture
Colorcon
Covington
AstraZeneca
Cipla
Chinese Patent Office
Moodys
Merck
Cerilliant

Generated: February 21, 2018

DrugPatentWatch Database Preview

Iron sucrose - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for iron sucrose and what is the scope of iron sucrose patent protection?

Iron sucrose
is the generic ingredient in one branded drug marketed by Luitpold and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are seventy-eight drug master file entries for iron sucrose. Two suppliers are listed for this compound.
Pharmacology for iron sucrose

US Patents and Regulatory Information for iron sucrose

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Luitpold VENOFER iron sucrose INJECTABLE;INTRAVENOUS 021135-001 Nov 6, 2000 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Luitpold VENOFER iron sucrose INJECTABLE;INTRAVENOUS 021135-003 Mar 29, 2005 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Luitpold VENOFER iron sucrose INJECTABLE;INTRAVENOUS 021135-005 Mar 29, 2013 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Luitpold VENOFER iron sucrose INJECTABLE;INTRAVENOUS 021135-004 Feb 9, 2007 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Luitpold VENOFER iron sucrose INJECTABLE;INTRAVENOUS 021135-002 Mar 20, 2005 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Argus Health
Fuji
Merck
Teva
UBS
Cerilliant
McKinsey
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot